Anzeige
Mehr »
Login
Sonntag, 19.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
GOLD-MINEN vor Jahrhundert-Hausse?! Diese Aktie sofort kaufen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EY43 | ISIN: US67011T3005 | Ticker-Symbol:
NASDAQ
17.05.24
21:49 Uhr
0,480 US-Dollar
-0,019
-3,77 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
NOVO INTEGRATED SCIENCES INC Chart 1 Jahr
5-Tage-Chart
NOVO INTEGRATED SCIENCES INC 5-Tage-Chart

Aktuelle News zur NOVO INTEGRATED SCIENCES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
15.04.Novo Integrated Sciences GAAP EPS of -$0.16, revenue of $3.17M5
15.04.Novo Integrated Sciences, Inc. - 10-Q, Quarterly Report2
15.04.Novo Integrated Sciences Reports Fiscal Year 2024 Second Quarter Financial Results83BELLEVUE, Wash.--(BUSINESS WIRE)--Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary...
► Artikel lesen
10.04.Novo Integrated Sciences, Inc. - 8-K, Current Report1
26.03.Novo Integrated Sciences, Inc. - 8-K, Current Report3
18.03.Novo Integrated Sciences, Inc. - 8-K, Current Report1
20.02.Novo Integrated Sciences secures Nasdaq compliance waiver2
16.02.Novo Integrated Sciences appoints new president3
15.02.Novo Integrated Sciences, Inc. - 8-K, Current Report3
22.01.Novo Integrated Sciences GAAP EPS of -$0.28, revenue of $3.89M4
22.01.Novo Integrated Sciences, Inc. - 10-Q, Quarterly Report1
22.01.Novo Integrated Sciences, Inc. - 8-K, Current Report1
22.01.Novo Integrated Sciences Reports Fiscal Year 2024 First Quarter Financial Results157BELLEVUE, Wash.--(BUSINESS WIRE)--Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary...
► Artikel lesen
16.01.Novo Integrated Sciences, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB2
14.12.23Novo Integrated Sciences GAAP EPS of -$1.30, revenue of $12.57M2
14.12.23Novo Integrated Sciences, Inc. - 8-K, Current Report1
14.12.23Novo Integrated Sciences Reports 2023 Fiscal Year Financial Results266BELLEVUE, Wash.--(BUSINESS WIRE)--Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary...
► Artikel lesen
14.12.23Novo Integrated Sciences, Inc. - 10-K, Annual Report2
04.12.23Novo Integrated Sciences, Inc. - 8-K, Current Report2
29.11.23Novo Integrated Sciences, Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT4053
Seite:  Weiter >>
29 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1